Skip to main content
Top
Published in: BMC Infectious Diseases 1/2015

Open Access 01-12-2015 | Research article

The estimated incidence of pertussis in people aged 50 years old in the United States, 2006–2010

Authors: Cristina Masseria, Girishanthy Krishnarajah

Published in: BMC Infectious Diseases | Issue 1/2015

Login to get access

Abstract

Background

Pertussis is believed to be widely underreported and under-recognized, particularly among adults. The aim of this study was to estimate the incidence of private practitioner-attended cough illness that could be attributed to Bordetella pertussis in adults aged ≥50 years in the US.

Methods

Multiple linear regressions were employed to estimate the overall incidence of pertussis. Data were extracted from IMS’ private practice database of longitudinal, patient-level claims and IMS’ commercial laboratory database during 4/1/2006–12/31/2010. Patients were ≥50 years old and had ≥1 ICD-9-CM claim for cough illness relating to pertussis, cough, or acute bronchitis. Pertussis positive laboratory tests, seasonal and secular variables were used for estimating the B. pertussis attributable fraction of cough illness.

Results

During the study period, there were 20.7 million cases of cough illness among people aged 50–64 and 27.5 million cases among those ≥65; of which the model attributed 2.5 and 1.7 %, respectively, to B. pertussis. The estimated incidences of cough illness attributed to B. pertussis during the study period were on average 202 and 257/100,000 among people aged 50–64 and ≥65 years, respectively, and increased over the years in both age groups. Depending on the year, estimated pertussis incidences were 42 to 105 times higher than medically attended ones in the same database.

Conclusions

These findings indicate that the B. pertussis disease incidence in adults aged ≥50 years is significantly higher than generally estimated. Additional research regarding pertussis reporting and diagnosis in the adult populations is needed to validate these findings.
Literature
1.
go back to reference Munoz FM, Keitel WA. Progress in the diagnosis, prevention, and treatment of pertussis. Curr Inf Dis Rep. 2003;5(3):213–9.CrossRef Munoz FM, Keitel WA. Progress in the diagnosis, prevention, and treatment of pertussis. Curr Inf Dis Rep. 2003;5(3):213–9.CrossRef
2.
go back to reference Zepp F, Heininger U, Mertsola J, Bernatowska E, Guiso N, Roord J, et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Inf Dis. 2011;11(7):557–70.CrossRef Zepp F, Heininger U, Mertsola J, Bernatowska E, Guiso N, Roord J, et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Inf Dis. 2011;11(7):557–70.CrossRef
3.
go back to reference Kretsinger K, Broder KR, Cortese MM, Joyce MP, Ortega-Sanchez I, Lee GM, et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep. 2006;55((RR-17):1–37. Kretsinger K, Broder KR, Cortese MM, Joyce MP, Ortega-Sanchez I, Lee GM, et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep. 2006;55((RR-17):1–37.
4.
go back to reference Cherry JD. Epidemic pertussis in 2012 - the resurgence of a vaccine-preventable disease. N Engl J Med. 2012;367(9):785–7.CrossRefPubMed Cherry JD. Epidemic pertussis in 2012 - the resurgence of a vaccine-preventable disease. N Engl J Med. 2012;367(9):785–7.CrossRefPubMed
5.
go back to reference Rothstein E, Edwards K. Health burden of pertussis in adolescents and adults. Pediatr Inf Dis J. 2005;24(5 Suppl):S44–47.CrossRef Rothstein E, Edwards K. Health burden of pertussis in adolescents and adults. Pediatr Inf Dis J. 2005;24(5 Suppl):S44–47.CrossRef
6.
go back to reference Bettiol S, Wang K, Thompson MJ, Roberts NW, Perera R, Heneghan CJ, et al. Symptomatic treatment of the cough in whooping cough. Cochrane Database Syst Rev. 2012;5:CD003257.PubMed Bettiol S, Wang K, Thompson MJ, Roberts NW, Perera R, Heneghan CJ, et al. Symptomatic treatment of the cough in whooping cough. Cochrane Database Syst Rev. 2012;5:CD003257.PubMed
7.
go back to reference Tan T, Trindade E, Skowronski D. Epidemiology of pertussis. Pediatr Inf Dis J. 2005;24(5 Suppl):S10–18.CrossRef Tan T, Trindade E, Skowronski D. Epidemiology of pertussis. Pediatr Inf Dis J. 2005;24(5 Suppl):S10–18.CrossRef
8.
go back to reference Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005;18(2):326–82.CrossRefPubMedPubMedCentral Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005;18(2):326–82.CrossRefPubMedPubMedCentral
9.
go back to reference Centers for Disease Control and Prevention (CDC). Pertussis epidemic - Washington, 2012. MMWR Morbid Mortal Wkly Rep. 2012;61:517–22. Centers for Disease Control and Prevention (CDC). Pertussis epidemic - Washington, 2012. MMWR Morbid Mortal Wkly Rep. 2012;61:517–22.
10.
go back to reference Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older - Advisory Committee on Immunization Practices (ACIP). MMWR Morbid Mortal Wkly Rep. 2012;61(25):468–70. Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older - Advisory Committee on Immunization Practices (ACIP). MMWR Morbid Mortal Wkly Rep. 2012;61(25):468–70.
11.
go back to reference Cherry JD, Tan T, Wirsing von Konig CH, Forsyth KD, Thisyakorn U, Greenberg D, et al. Clinical definitions of pertussis: Summary of a Global Pertussis Initiative roundtable meeting, February 2011. Clin Infect Dis. 2012;54(12):1756–64.CrossRefPubMedPubMedCentral Cherry JD, Tan T, Wirsing von Konig CH, Forsyth KD, Thisyakorn U, Greenberg D, et al. Clinical definitions of pertussis: Summary of a Global Pertussis Initiative roundtable meeting, February 2011. Clin Infect Dis. 2012;54(12):1756–64.CrossRefPubMedPubMedCentral
12.
go back to reference Prince HE, Lieberman JM, Cherry JD. Age-related differences in patterns of increased Bordetella pertussis antibodies. Clin Vacc Immunol. 2012;19(4):545–50.CrossRef Prince HE, Lieberman JM, Cherry JD. Age-related differences in patterns of increased Bordetella pertussis antibodies. Clin Vacc Immunol. 2012;19(4):545–50.CrossRef
14.
go back to reference Cherry JD, Seaton BL. Patterns of Bordetella parapertussis respiratory illnesses: 2008–2010. Clin Infect Dis. 2012;54(4):534–7.CrossRefPubMed Cherry JD, Seaton BL. Patterns of Bordetella parapertussis respiratory illnesses: 2008–2010. Clin Infect Dis. 2012;54(4):534–7.CrossRefPubMed
15.
go back to reference Paget WJ, Balderston C, Casas I, Donker G, Edelman L, Fleming D, et al. Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project. Eur J Pediatr. 2010;169(8):997–1008.CrossRefPubMedPubMedCentral Paget WJ, Balderston C, Casas I, Donker G, Edelman L, Fleming D, et al. Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project. Eur J Pediatr. 2010;169(8):997–1008.CrossRefPubMedPubMedCentral
16.
go back to reference Pitman RJ, Melegaro A, Gelb D, Siddiqui MR, Gay NJ, Edmunds WJ. Assessing the burden of influenza and other respiratory infections in England and Wales. J Inf. 2007;54(6):530–8.CrossRef Pitman RJ, Melegaro A, Gelb D, Siddiqui MR, Gay NJ, Edmunds WJ. Assessing the burden of influenza and other respiratory infections in England and Wales. J Inf. 2007;54(6):530–8.CrossRef
17.
go back to reference Olson DR, Heffernan RT, Paladini M, Konty K, Weiss D, Mostashari F. Monitoring the impact of influenza by age: emergency department fever and respiratory complaint surveillance in New York City. PLoS Med. 2007;4(8):e247.CrossRefPubMedPubMedCentral Olson DR, Heffernan RT, Paladini M, Konty K, Weiss D, Mostashari F. Monitoring the impact of influenza by age: emergency department fever and respiratory complaint surveillance in New York City. PLoS Med. 2007;4(8):e247.CrossRefPubMedPubMedCentral
18.
go back to reference McGuiness CB, Hill J, Fonseca E, Hess G, Hitchcock W, Krishnarajah G. The disease burden of pertussis in adults 50 years old and older in the United States: a retrospective study. BMC Inf Dis. 2013;13(1):32.CrossRef McGuiness CB, Hill J, Fonseca E, Hess G, Hitchcock W, Krishnarajah G. The disease burden of pertussis in adults 50 years old and older in the United States: a retrospective study. BMC Inf Dis. 2013;13(1):32.CrossRef
21.
go back to reference Toback SL, Herley J, Edelman L, Ambrose CS. Trends in U.S. pediatric influenza vaccination from 2006 to 2010 among children with private insurance. Vaccine. 2011;29(25):4225–9.CrossRefPubMed Toback SL, Herley J, Edelman L, Ambrose CS. Trends in U.S. pediatric influenza vaccination from 2006 to 2010 among children with private insurance. Vaccine. 2011;29(25):4225–9.CrossRefPubMed
22.
go back to reference Ryan MJ, Ramsay M, Brown D, Gay NJ, Farrington CP, Wall PG. Hospital admissions attributable to rotavirus infection in England and Wales. J Inf Dis. 1996;174 Suppl 1:S12–18.CrossRef Ryan MJ, Ramsay M, Brown D, Gay NJ, Farrington CP, Wall PG. Hospital admissions attributable to rotavirus infection in England and Wales. J Inf Dis. 1996;174 Suppl 1:S12–18.CrossRef
23.
go back to reference Muller-Pebody B, Edmunds WJ, Zambon MC, Gay NJ, Crowcroft NS. Contribution of RSV to bronchiolitis and pneumonia-associated hospitalizations in English children, April 1995-March 1998. Epidemiol Inf. 2002;129(1):99–106.CrossRef Muller-Pebody B, Edmunds WJ, Zambon MC, Gay NJ, Crowcroft NS. Contribution of RSV to bronchiolitis and pneumonia-associated hospitalizations in English children, April 1995-March 1998. Epidemiol Inf. 2002;129(1):99–106.CrossRef
24.
go back to reference Stolwijk AM, Straatman H, Zielhuis GA. Studying seasonality by using sine and cosine functions in regression analysis. J Epidemiol Commun Health. 1999;53(4):235–8.CrossRef Stolwijk AM, Straatman H, Zielhuis GA. Studying seasonality by using sine and cosine functions in regression analysis. J Epidemiol Commun Health. 1999;53(4):235–8.CrossRef
25.
go back to reference Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289(2):179–86.CrossRefPubMed Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289(2):179–86.CrossRefPubMed
26.
go back to reference Liao CM, Chang SY, Chen SC, Chio CP. Influenza-associated morbidity in subtropical Taiwan. Int J Inf Dis. 2009;13(5):589–99.CrossRef Liao CM, Chang SY, Chen SC, Chio CP. Influenza-associated morbidity in subtropical Taiwan. Int J Inf Dis. 2009;13(5):589–99.CrossRef
27.
go back to reference Cherry JD. The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics. 2005;115(5):1422–7.CrossRefPubMed Cherry JD. The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics. 2005;115(5):1422–7.CrossRefPubMed
28.
go back to reference Ward JI, Cherry JD, Chang SJ, Partridge S, Lee H, Treanor J, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med. 2005;353(15):1555–63.CrossRefPubMed Ward JI, Cherry JD, Chang SJ, Partridge S, Lee H, Treanor J, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med. 2005;353(15):1555–63.CrossRefPubMed
29.
go back to reference Hodder SL, Cherry JD, Mortimer Jr EA, Ford AB, Gornbein J, Papp K. Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents. Clin Infect Dis. 2000;31(1):7–14.CrossRefPubMed Hodder SL, Cherry JD, Mortimer Jr EA, Ford AB, Gornbein J, Papp K. Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents. Clin Infect Dis. 2000;31(1):7–14.CrossRefPubMed
30.
go back to reference Centers for Disease Control and Prevention (CDC). Summary of notifiable diseases - United States, 2010. MMWR Morbid Mortal Wkly Rep. 2012;59(53):1–111. Centers for Disease Control and Prevention (CDC). Summary of notifiable diseases - United States, 2010. MMWR Morbid Mortal Wkly Rep. 2012;59(53):1–111.
31.
go back to reference Nennig ME, Shinefield HR, Edwards KM, Black SB, Fireman BH. Prevalence and incidence of adult pertussis in an urban population. JAMA. 1996;275(21):1672–4.CrossRefPubMed Nennig ME, Shinefield HR, Edwards KM, Black SB, Fireman BH. Prevalence and incidence of adult pertussis in an urban population. JAMA. 1996;275(21):1672–4.CrossRefPubMed
32.
go back to reference Strebel P, Nordin J, Edwards K, Hunt J, Besser J, Burns S, et al. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995–1996. J Inf Dis. 2001;183(9):1353–9.CrossRef Strebel P, Nordin J, Edwards K, Hunt J, Besser J, Burns S, et al. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995–1996. J Inf Dis. 2001;183(9):1353–9.CrossRef
33.
go back to reference Dragsted DM, Dohn B, Madsen J, Jensen JS. Comparison of culture and PCR for detection of Bordetella pertussis and Bordetella parapertussis under routine laboratory conditions. J Med Microbiol. 2004;53(Pt 8):749–54.CrossRefPubMed Dragsted DM, Dohn B, Madsen J, Jensen JS. Comparison of culture and PCR for detection of Bordetella pertussis and Bordetella parapertussis under routine laboratory conditions. J Med Microbiol. 2004;53(Pt 8):749–54.CrossRefPubMed
34.
go back to reference Dalby T, Fry NK, Krogfelt KA, Jensen JS, He Q. Evaluation of PCR methods for the diagnosis of pertussis by the European surveillance network for vaccine-preventable diseases (EUVAC.NET). Eur J Clin Microbiol Infect Dis. 2013;32:1285–9.CrossRefPubMed Dalby T, Fry NK, Krogfelt KA, Jensen JS, He Q. Evaluation of PCR methods for the diagnosis of pertussis by the European surveillance network for vaccine-preventable diseases (EUVAC.NET). Eur J Clin Microbiol Infect Dis. 2013;32:1285–9.CrossRefPubMed
35.
go back to reference Centers for Disease Control and Prevention (CDC). Local health department costs associated with response to a school-based pertussis outbreak - Omaha, Nebraska, September-November 2008. MMWR Morbid Mortal Wkly Rep. 2011;60(1):5–9. Centers for Disease Control and Prevention (CDC). Local health department costs associated with response to a school-based pertussis outbreak - Omaha, Nebraska, September-November 2008. MMWR Morbid Mortal Wkly Rep. 2011;60(1):5–9.
36.
go back to reference Witt MA, Katz PH, Witt DJ. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis. 2012;54(12):1730–5.CrossRefPubMed Witt MA, Katz PH, Witt DJ. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis. 2012;54(12):1730–5.CrossRefPubMed
37.
go back to reference Sotir MJ, Cappozzo DL, Warshauer DM, Schmidt CE, Monson TA, Berg JL, et al. A countywide outbreak of pertussis: initial transmission in a high school weight room with subsequent substantial impact on adolescents and adults. Arch Pediatr Adolesc Med. 2008;162(1):79–85.CrossRefPubMed Sotir MJ, Cappozzo DL, Warshauer DM, Schmidt CE, Monson TA, Berg JL, et al. A countywide outbreak of pertussis: initial transmission in a high school weight room with subsequent substantial impact on adolescents and adults. Arch Pediatr Adolesc Med. 2008;162(1):79–85.CrossRefPubMed
38.
go back to reference Craig AS, Wright SW, Edwards KM, Greene JW, Haynes M, Dake AD, et al. Outbreak of pertussis on a college campus. Am J Med. 2007;120(4):364–8.CrossRefPubMed Craig AS, Wright SW, Edwards KM, Greene JW, Haynes M, Dake AD, et al. Outbreak of pertussis on a college campus. Am J Med. 2007;120(4):364–8.CrossRefPubMed
39.
go back to reference Kretzschmar M, Teunis PF, Pebody RG. Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European countries. PLoS Med. 2010;7(6):e1000291.CrossRefPubMedPubMedCentral Kretzschmar M, Teunis PF, Pebody RG. Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European countries. PLoS Med. 2010;7(6):e1000291.CrossRefPubMedPubMedCentral
Metadata
Title
The estimated incidence of pertussis in people aged 50 years old in the United States, 2006–2010
Authors
Cristina Masseria
Girishanthy Krishnarajah
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2015
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-015-1269-1

Other articles of this Issue 1/2015

BMC Infectious Diseases 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine